Lecture

Flow Cytometry: An Invaluable Tool for Research and Clinical Applications

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

In course

BIO-447: Stem cells and organoids

This course introduces the fundamentals of stem cell biology, with a particular focus on the role of stem cells during development, tissue homeostasis/regeneration and disease, and the generation of organoids from stem cells ...

Description

This lecture introduces Flow Cytometry as a technology for rapid multi-parametric analysis of single cells, using lasers to produce scattered and fluorescent light signals. It covers its applications in various disciplines such as immunology, stem cell biology, cancer biology, and infectious disease monitoring. The lecture explains the components of a Flow Cytometer, the process of labeling cells with fluorescent dyes, and the importance of compensation to correct spectral overlap in data analysis.

Instructors (4)

Freddy Radtke

Freddy Radtke obtained his Ph.D. in Molecular Biology from the University of Zürich in 1994. In 1995, he started his postdoctoral research in the laboratory of Michel Aguet at Genentech, Inc. (San Francisco, USA). In 1997, he returned to Switzerland with Michel Aguet and finished his postdoctoral fellowship at the Swiss Institute for Experimental Cancer Research (ISREC) in Lausanne. From 1999‑2005, he was a group leader and Associate Member at the Ludwig Institute for Cancer Research. Freddy Radtke then joined ISREC in January 2006 as a senior scientist and in July 2006, he was appointed Associate Professor at the EPFL School of Life Sciences

David Michael Suter

Teaching & PhD PhD Students Ekaterina Lyublinskaya, Yuliia Romaniuk, Joanna Agnieszka Dembska, Solomon Nshemereirwe Past EPFL PhD Students Onur Tidin, Aleksandra Mandic, Daniel Strebinger, Andrea Brigitta Alber, Mahé Raccaud, Torgil Elias Friman, Shoujie Sun, Silja Michelle Placzek, Romane Mizeret, Benjamin Martin, Sim Sakong, Stella Katharina Krämer Past EPFL PhD Students as codirector Damien Lionel Nicolas, Isabelle Chareyron, Christopher Tadhg James Wall, Kolly Dominique Courses Immunology BI

Wouter Richard Karthaus

Teaching & PhD PhD Students Jillian Rose Love, Estelle Deby, Ester Simkova, Turan Badalli Courses Cellular and molecular biology II BIO-207 This course is aimed to familiarize students with the 3D organization of a eukaryotic cell, its compartmentalization, how cellular compartments communicate together and how a cell communicates with its environment. The related molecular mechanisms will be discussed. Practical - Karthaus Lab BIO-616 Students will learn 1) how organoids c

Matthias Lütolf

Matthias Lutolf is Full Professor at EPFL’s Institute of Bioengineering, with a cross appointment in the Institute of Chemical Sciences and Engineering. Lutolf was trained as a Materials Engineer at ETH Zurich where he also carried out his PhD studies (with Jeffrey Hubbell) that were awarded with an ETH medal. He continued his research training as a Post-Doctoral Fellow in Stem Cell Biology (with Helen Blau) at Stanford University. He has served as the Director of the Institute of Bioengineering from 2014 to 2018. Lutolf is an internationally recognized leader in the fields of stem cell bioengineering and tissue engineering. His research program uniquely combines stem cell biology with engineering principles and quantitative thinking. His team, composed of engineers, chemists, physicists, cell and developmental biologists, strives to develop technologies that have true biological and medicinal function and applicability. Lutolf’s work has led to more than 110 peer-reviewed scientific publications, many of which published in highly reputed journals, more than 25 patents, and the commercialization of several products. Current research in the Lutolf lab is focused on the bioengineering of miniature tissues, termed organoids, that are generated from self-organizing stem cells.

Official source

Related concepts (32)

Stem cell

In multicellular organisms, stem cells are undifferentiated or partially differentiated cells that can differentiate into various types of cells and proliferate indefinitely to produce more of the same stem cell. They are the earliest type of cell in a cell lineage. They are found in both embryonic and adult organisms, but they have slightly different properties in each. They are usually distinguished from progenitor cells, which cannot divide indefinitely, and precursor or blast cells, which are usually committed to differentiating into one cell type.

Adult stem cell

Adult stem cells are undifferentiated cells, found throughout the body after development, that multiply by cell division to replenish dying cells and regenerate damaged tissues. Also known as somatic stem cells (from Greek σωματικóς, meaning of the body), they can be found in juvenile, adult animals, and humans, unlike embryonic stem cells. Scientific interest in adult stem cells is centered around two main characteristics.

Embryonic stem cell

Embryonic stem cells (ESCs) are pluripotent stem cells derived from the inner cell mass of a blastocyst, an early-stage pre-implantation embryo. Human embryos reach the blastocyst stage 4–5 days post fertilization, at which time they consist of 50–150 cells. Isolating the inner cell mass (embryoblast) using immunosurgery results in destruction of the blastocyst, a process which raises ethical issues, including whether or not embryos at the pre-implantation stage have the same moral considerations as embryos in the post-implantation stage of development.

Stem-cell therapy

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. , the only established therapy using stem cells is hematopoietic stem cell transplantation. This usually takes the form of a bone-marrow transplantation, but the cells can also be derived from umbilical cord blood. Research is underway to develop various sources for stem cells as well as to apply stem-cell treatments for neurodegenerative diseases and conditions such as diabetes and heart disease.

Stem cell controversy

The stem cell controversy is the consideration of the ethics of research involving the development and use of human embryos. Most commonly, this controversy focuses on embryonic stem cells. Not all stem cell research involves human embryos. For example, adult stem cells, amniotic stem cells, and induced pluripotent stem cells do not involve creating, using, or destroying human embryos, and thus are minimally, if at all, controversial.

Related lectures (64)

Flow Cytometry: Applications and Techniques

Explores the applications and techniques of flow cytometry, including cell characterization and sorting methods.

Stem Cell Biology: Essentials and Applications

Covers the essentials of stem cell biology, including major types, properties, and applications, as well as challenges in research.

Stem Cells and Organoid Engineering

Delves into the rise of organoids and gastruloids through stem cell cultivation, exploring the potential applications of human stem cells.

Airway Tissue Engineering: Anatomy, Physiology, and Future Developments

Explores airway anatomy, clinical conditions, ideal replacements, available options, and future developments in tissue engineering.

Stem Cell Applications: Models, Therapy, and Cloning